Global warming is having a noticeable effect on things from animal life to glaciers, to weather patterns and food production. Even human health, is not immune from the ravages of climate change.
According to research, a changing climate due to global warming can exacerbate the symptoms of existing seasonal allergies, as well as cause new cases.
Allergy Therapeutics (LON:AGY) is an international commercial biotechnology group focused on the treatment and diagnosis of allergic disorders, including immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third-party products from its subsidiaries in nine major European countries and via distribution agreements in an additional fourteen countries. Its broad pipeline of products in clinical development include vaccines for grass, tree and house dust mite, and peanut allergy vaccine in pre-clinical development. Adjuvant systems to boost performance of vaccines outside allergy are also in development.